K. Komuta
Impact in
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Oncology top 10%
- Lung Cancer Research Studies
- Drug Transport and Resistance Mechanisms
Papers in
-
- Lung Cancer Treatments and Mutations 11
- Lung Cancer Diagnosis and Treatment 3
- Oncology 11
- Lung Cancer Research Studies 5
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- K. Maeda (1 shared paper)Ryo Kimura (1 shared paper)Soichiro Yokota (4 shared papers)Seigo Minami (5 shared papers)Yasushi Sakamaki (1 shared paper)Kengo Takeuchi (1 shared paper)Takashi Yamasaki (1 shared paper)Masahiko Tsujimoto (1 shared paper)
- Journals
- Lung Cancer (4 papers)Annals of Oncology (3 papers)British Journal of Cancer (3 papers)Journal of Clinical Oncology (2 papers)Journal of Clinical Pathology (1 paper)
- Partner nations
- Japan
In The Last Decade
K. Komuta
17 papers receiving 567 citations
Peers
Comparison fields: 5 of 52
- Pharmacology 130
- Oncology 199
- Pulmonary and Respiratory Medicine 173
- Epidemiology 119
- Cancer Research 45
Countries citing papers authored by K. Komuta
This map shows the geographic impact of K. Komuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Komuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Komuta more than expected).
Fields of papers citing papers by K. Komuta
This network shows the impact of papers produced by K. Komuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Komuta. The network helps show where K. Komuta may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Komuta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. | 2000 | 189 |
| 2 | 2010 | 112 | |
| 3 | 1997 | 77 | |
| 4 | 2009 | 69 | |
| 5 | Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity. | 1988 | 39 |
| 6 | 1987 | 26 | |
| 7 | 2013 | 22 | |
| 8 | 2003 | 16 | |
| 9 | 2005 | 11 | |
| 10 | 2006 | 5 | |
| 11 | 2000 | 4 | |
| 12 | 2018 | 3 | |
| 13 | Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease | 2015 | 2 |
| 14 | 2012 | 2 | |
| 15 | 1996 | 2 | |
| 16 | 2010 | 1 | |
| 17 | [Improvement in quality of life with vinorelbine as a single agent in two patients with recurrent lung cancer]. | 2000 | 1 |
| 18 | 2012 | 0 | |
| 19 | 2019 | 0 | |
| 20 | 2025 | 0 |
About K. Komuta
K. Komuta is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Pathology and Forensic Medicine and Epidemiology, having authored 20 papers that have together received 581 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (5 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Immune Cell Function and Interaction (2 papers), Cancer therapeutics and mechanisms (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pharmacology (130 citations), Oncology (199 citations), Pulmonary and Respiratory Medicine (173 citations), Epidemiology (119 citations) and Cancer Research (45 citations). K. Komuta has collaborated with scholars based in Japan. Frequent co-authors include K. Maeda, Ryo Kimura, Soichiro Yokota, Seigo Minami, Yasushi Sakamaki, Kengo Takeuchi, Takashi Yamasaki, Masahiko Tsujimoto, Masahiko Ito and T. Igarashi. Their work appears in journals such as Lung Cancer, Annals of Oncology, British Journal of Cancer, Journal of Clinical Oncology and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.